Drawing for KOWYNTO

USPTO serial 99784638

KOWYNTO

Reviewed by CopyMark Law Group

Reg. 8501184Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
MCCLELLAN, MATTHEW D.
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KOWYNTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra M. Vaccaro

Alexandra M. Vaccaro Merck & Co., Inc.126 E. Lincoln AvenueRahway, NJ 07065United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 31, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 30, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 24, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 24, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 24, 2026CNSLSUSPENSION LETTER WRITTEN—
Jul 22, 2026DOCKASSIGNED TO EXAMINER—
Apr 24, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 24, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance